Effect of Nursing Intervention on Mothers' Knowledge of Cervical Cancer and Acceptance of Human Papillomavirus Vaccination for Their Adolescent Daughters in Abuja - Nigeria

Overview

Journal Asia Pac J Oncol Nurs

Publisher Elsevier

Date 2018 Apr 3

PMID 29607384

Citations 6

Authors

Funmilola T Odunyemi

Chizoma M Ndikom

O Abimbola Oluwatosin

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this study is to evaluate the effect of nursing intervention on mothers' knowledge of cervical cancer and acceptance of human papillomavirus (HPV) vaccination for their adolescent daughters in Abuja, Nigeria.

Methods: This was a quasi-experimental study that utilized two groups pre and post-test design. The study was carried out among civil servant mothers in Bwari (experimental group [EG]) and Kwali (control group[CG]) Area Councils of Abuja, Nigeria. One hundred and forty-six women who met the inclusion criteria were purposively selected for this study. EG consists of 69 women while 77 are from CG. The intervention consisted of two days workshop on cervical cancer and HPV vaccination. Descriptive and inferential analyses of the data were performed using SPSS software 20 version.

Results: The mean age of the respondents was 35 years ± 6.6 in the EG and 41 years ± 8.2 in the CG. The mean knowledge score of cervical cancer was low at baseline in both EG (9.58 ± 7.1) and CG (11.61 ± 6.5). However, there was a significant increase to 21.45 ± 6.2 after the intervention in EG ( < 0.0001). The baseline acceptance of HPV vaccination was high in EG after intervention from 74% to 99%. Exposure to nursing intervention and acceptance of HPV vaccination was statistically significant after intervention ( < 0.0001).

Conclusions: The nursing intervention has been found to increase mothers' knowledge of cervical cancer and acceptance of HPV vaccination. It is therefore recommended that nurses should use every available opportunity in mothers' clinic to educate on cervical cancer and HPV vaccination.

Citing Articles

Vaccination Communication Strategies and Uptake in Africa: A Systematic Review.

Ekezie W, Igein B, Varughese J, Butt A, Ukoha-Kalu B, Ikhile I Vaccines (Basel). 2025; 12(12.

PMID: 39771995 PMC: 11679460. DOI: 10.3390/vaccines12121333.

A Six-Week Smartphone-Based Program for HPV Prevention Among Mothers of School-Aged Boys: A Quasi-Experimental Study in South Korea.

Cho Y, Kim T Healthcare (Basel). 2024; 12(23).

PMID: 39685082 PMC: 11641219. DOI: 10.3390/healthcare12232460.

A designathon to co-create HPV screening and vaccination approaches for mothers and daughters in Nigeria: findings from a community-led participatory event.

Kpokiri E, Wapmuk A, Obiezu-Umeh C, Nwaozuru U, Gbaja-Biamila T, Obionu I BMC Infect Dis. 2024; 24(1):606.

PMID: 38902607 PMC: 11188243. DOI: 10.1186/s12879-024-09479-7.

Parental Knowledge of HPV Infection, Cervical Cancer and the Acceptance of HPV Vaccination for their Children in Jos, Nigeria.

Anyaka C, Alero B, Olukoya B, Envuladu E, Musa J, Sagay A J West Afr Coll Surg. 2024; 14(2):146-153.

PMID: 38562384 PMC: 10980327. DOI: 10.4103/jwas.jwas_309_22.

Cervical Cancer and Human Papillomavirus Vaccine Knowledge, Utilisation, Prevention Educational Interventions and Policy Response in Nigeria: A Scoping Review.

John-Akinola Y, Ndikom C, Oluwasanu M, Adebisi T, Odukoya O Cancer Control. 2022; 29:10732748221130180.

PMID: 36168955 PMC: 9523857. DOI: 10.1177/10732748221130180.

References

Akarolo-Anthony S, Famooto A, Dareng E, Olaniyan O, Offiong R, Wheeler C . Age-specific prevalence of human papilloma virus infection among Nigerian women. BMC Public Health. 2014; 14:656. PMC: 4094683. DOI: 10.1186/1471-2458-14-656. View

Ezeanochie M, Olagbuji B . Human papilloma virus vaccine: determinants of acceptability by mothers for adolescents in Nigeria. Afr J Reprod Health. 2014; 18(3):154-8. View

Perlman S, Wamai R, Bain P, Welty T, Welty E, Ogembo J . Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review. PLoS One. 2014; 9(3):e90912. PMC: 3949716. DOI: 10.1371/journal.pone.0090912. View

Okolo C, Franceschi S, Adewole I, Thomas J, Follen M, Snijders P . Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria. Infect Agent Cancer. 2010; 5(1):24. PMC: 3017010. DOI: 10.1186/1750-9378-5-24. View

Chang I, Huang R, He W, Zhang S, Wang S, Zhao F . Effect of an educational intervention on HPV knowledge and vaccine attitudes among urban employed women and female undergraduate students in China: a cross-sectional study. BMC Public Health. 2013; 13:916. PMC: 3852612. DOI: 10.1186/1471-2458-13-916. View

Chidyaonga-Maseko F, Chirwa M, Muula A . Underutilization of cervical cancer prevention services in low and middle income countries: a review of contributing factors. Pan Afr Med J. 2015; 21:231. PMC: 4607967. DOI: 10.11604/pamj.2015.21.231.6350. View

Bello F, Enabor O, Adewole I . Human papilloma virus vaccination for control of cervical cancer: a challenge for developing countries. Afr J Reprod Health. 2011; 15(1):25-30. View

Moustafa A, Al-Awadhi R, Missaoui N, Adam I, Durusoy R, Ghabreau L . Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regions. Hum Vaccin Immunother. 2014; 10(7):1812-21. PMC: 4186051. DOI: 10.4161/hv.28742. View

Umezulike A, Tabansi S, Ewunonu H, Nwana E . Epidemiological characteristics of carcinoma of the cervix in the Federal capital Territory of Nigeria. Niger J Clin Pract. 2007; 10(2):143-6. View

10.

Mak W, Ching S . Effect of an education program on knowledge, self-care behavior and handwashing competence on prevention of febrile neutropenia among breast cancer patients receiving Doxorubicin and Cyclophosphamide in Chemotherapy Day Centre. Asia Pac J Oncol Nurs. 2016; 2(4):276-288. PMC: 5123502. DOI: 10.4103/2347-5625.167232. View

11.

Banura C, Mirembe F, Katahoire A, Namujju P, Mbidde E . Universal routine HPV vaccination for young girls in Uganda: a review of opportunities and potential obstacles. Infect Agent Cancer. 2012; 7(1):24. PMC: 3523036. DOI: 10.1186/1750-9378-7-24. View

12.

Bartolini R, Winkler J, Penny M, Scott Lamontagne D . Parental acceptance of HPV vaccine in Peru: a decision framework. PLoS One. 2012; 7(10):e48017. PMC: 3483308. DOI: 10.1371/journal.pone.0048017. View

13.

Ganesan S, Subbiah V, Michael J . Associated factors with cervical pre-malignant lesions among the married fisher women community at Sadras, Tamil Nadu. Asia Pac J Oncol Nurs. 2016; 2(1):42-50. PMC: 5123457. DOI: 10.4103/2347-5625.146223. View

14.

Wright K, Faseru B, Kuyinu Y, Faduyile F . Awareness and uptake of the Pap smear among market women in Lagos, Nigeria. J Public Health Afr. 2017; 2(1):e14. PMC: 5345473. DOI: 10.4081/jphia.2011.e14. View

15.

Isa Modibbo F, Dareng E, Bamisaye P, Jedy-Agba E, Adewole A, Oyeneyin L . Qualitative study of barriers to cervical cancer screening among Nigerian women. BMJ Open. 2016; 6(1):e008533. PMC: 4716205. DOI: 10.1136/bmjopen-2015-008533. View

16.

Carter D . New global survey shows an increasing cancer burden. Am J Nurs. 2014; 114(3):17. DOI: 10.1097/01.NAJ.0000444482.41467.3a. View

17.

Ahmed S, Sabitu K, Idris S, Ahmed R . Knowledge, attitude and practice of cervical cancer screening among market women in Zaria, Nigeria. Niger Med J. 2014; 54(5):316-9. PMC: 3883231. DOI: 10.4103/0300-1652.122337. View

18.

Bosch F, Burchell A, Schiffman M, Giuliano A, de Sanjose S, Bruni L . Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine. 2008; 26 Suppl 10:K1-16. DOI: 10.1016/j.vaccine.2008.05.064. View

19.

Ozyer S, Uzunlar O, Ozler S, Kaymak O, Baser E, Gungor T . Awareness of Turkish female adolescents and young women about HPV and their attitudes towards HPV vaccination. Asian Pac J Cancer Prev. 2013; 14(8):4877-81. DOI: 10.7314/apjcp.2013.14.8.4877. View

20.

Adedini S, Odimegwu C, Bamiwuye O, Fadeyibi O, De Wet N . Barriers to accessing health care in Nigeria: implications for child survival. Glob Health Action. 2014; 7:23499. PMC: 3957799. DOI: 10.3402/gha.v7.23499. View